DNDi Innovation & Access – Partners’ Meeting 2016

June 6-8, 2016
Rio de Janeiro, Brazil

Partners’ Meeting

Date: June 8, 2016
Venue: Hotel Rio Othon Palace Av. Atlantica, 3264 – Copacabana

 

Opening Ceremony

Time: 08:30-10:00

 
 Welcome

Marcel Tanner, DNDi Board Chair and Professor and Chair of Epidemiology & Medical Parasitology, University of Basel & Federal Institute of Technology, Switzerland

Opening Addresses

Alejandro Gaviria Uribe, Minister of Health & Social Protection of Colombia

Jorge Bermudez, Vice President of Health Production & Innovation, Fiocruz, Minister of Health of Brazil


Innovation & access for neglected populations, a dynamic approach towards 2023
Bernard Pécoul,
Executive Director, DNDi

Key challenges and prospects for Latin America
Joël Keravec, Regional Executive Director, DNDi Latin America

 Closing Remarks
Joël Keravec, Regional Executive Director, DNDi Latin America

 

 

Panel Discussions

10:30-11:30

Session 1: Innovation & access for Chagas disease

Chair: Mercedes Tatay, International Medical Secretary, MSF Switzerland

Respondents:

  • Sergio Sosa-Estani, Director, Insituto Fatala Chaben
  • Nancy Dominga da Costa, President of the Rio Chagas Association
  • Marcelo Paganini, Executive Director, Mundo Sano
  • Isabela Ribeiro, Head of Chagas Clinical Program, DNDi
  • Oscar Bernal, Director of the Master’s in Public Health Program, Los Andes University
 
11:30-12:30

Session 2: Innovation & access for Leishmaniasis

Chair: Renato Alves, Head of the Vector Born Disease Unit, Ministry of Health Brazil

Respondents:

  • Ivano Dario Velez, Director, PECET, University of Antioquia
  • Ana Nilce Elkhoury, Regional Advisor of Leishmaniasis, PAHO
  • Gustavo Romero, Professor, University of Brazil
  • Moacir Zini, Patient Representative, Mato Grosso State
  • Byron Arana, Head of Cutaneous Leishmaniasis, DNDi
 
14:00-14:45 Keynote Discussion
Zika, Chagas, Hepatitis C: From emergencies to Sustainable Innovation & Access in Latin America and the Rest of the World

Chair: Marcel Tanner,
DNDi Board Chair, Professor & Chair of Epidemiology & Medical Parasitology, University of Basel & Federal Institute of Technology, Switzerland

Respondents:

  • Nick White, Professor of Tropical Medicine, Mahidol University
  • Nila Heredia, President, ASOFAMD and Former Minister of Health & Sports, Bolivia
  • Noor Hisham Abdullah, Director General of Health, Ministry of Health, Malaysia
 
14:45-15:45

Session 3: The role of innovative funding initiatives for global health needs

Chair: Dr Els Torreele, Director, Access to Essential Medicines, Open Society Foundations

Respondents:

  • Elkin Echeverri, Director of Planning and Strategy, Ruta N
  • João Paulo Pieroni, Head of Pharmaceutical Products, BNDES
  • Draurio Barreira, Manager, Tuberculosis, Strategy and Results, UNITAID
  • Joël Keravec, Regional Executive Director, DNDi Latin America
  • Suerie Moon, Research Director at the Harvard School of Public Health
 
15:45-16:45

Session 4: How to address emerging public health challenges & priorities

Chair: Nirmal K. Ganguly, Advisor and Professor, Translational Health Science & Technology Institute, India National Institute of Immunology

Respondents:

  • Claudia Vaca, Pharmacoepidemiologist, Professor at the Department of Pharmacy, National University, Colombia
  • Manica Balasegaram, Director, Global Antibiotic R&D (GARD, DNDi) Partnership
  • Yasser Mohamed Fayed, Business Development Director,  Pharco Pharmaceuticals
  • Jorge Bermudez, Vice President of Health Production and Innovation, Fiocruz
  • Bernard Pécoul, Executive Director, DNDi
 

Closing Ceremony

17:00-18:00

Closing Remarks: Awards and Farewell

Chair: Prof Marcel Tanner, Chair

  • Project of the Year
  • Partnership of the Year
  • Innovative Funding Mechanism

 

Download the Full Programme